Back to discover
Disease

Neoplasms, Neuroepithelial

Active therapeutic pipelineEmerging research
MeSHNeoplasms, Neuroepithelial
1
Publications
2
Clinical trials
2020
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Pediatric low-grade glioma in the era of molecular diagnostics.

Research2020-03-12Acta neuropathologica communications

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q3 2026.
Upcoming Milestones
Major developments
Upcoming trial readoutImportant
Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Results expected Q3 20262026-05-15
Clinical Milestones1View
Results expected 1
Activity timeline1

Clinical trials

2 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
2
All trials
1
Active
0
Late-stage
1
Completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Pediatric low-grade glioma in the era of molecular diagnostics.

Acta neuropathologica communications · 2020 · 258 cites
Recent publications

Pediatric low-grade glioma in the era of molecular diagnostics.

Acta neuropathologica communications · 2020 · 258 cites
Leading journals1
  • Acta neuropathologica communications1
Leading researchers3
  • Hawkins C1
  • Ryall S1
  • Tabori U1
Affiliations (unnormalised)4
  • Arthur and Sonia Labatt Brain Tumour Research Centre1
  • Department of Laboratory Medicine and Pathobiology1
  • The Hospital for Sick Children1
  • University of Toronto1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. (From Dev Biol 1998 Aug 1;200(1):1-5)

Identifiers
MeSHNeoplasms, Neuroepithelial
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.